Journey Medical (DERM) Revenue (2020 - 2026)

Journey Medical has reported Revenue for 7 years, with the latest figure at $15.9 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 21.17% year-over-year to $15.9 million; the trailing twelve-month figure through Mar 2026 stood at $64.0 million (up 13.85% YoY), and the FY2025 full-year result was $61.9 million, up 10.2% from the prior year.
• Revenue for Q1 2026 stood at $15.9 million, down from $16.1 million in the prior quarter.
• The five-year high for Revenue was $20.8 million in Q1 2022, with the low at -$4.3 million in Q4 2023.
• Historically, Revenue has averaged $14.6 million across 5 years, with a median of $15.3 million in 2023.
• Annual changes were most pronounced in 2023 — Revenue sank 122.92% — and 2024, when it soared 419.57%.
• Journey Medical's Revenue stood at $18.6 million in 2022, then slumped by 122.92% to -$4.3 million in 2023, then soared by 419.57% to $13.6 million in 2024, then rose by 18.05% to $16.1 million in 2025, then dropped by 0.98% to $15.9 million in 2026.
• The last three Revenue figures came in at $15.9 million (Q1 2026), $16.1 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.